Research article Special Issues

Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data

  • We model the COVID-19 coronavirus epidemic in China. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.

    Citation: Zhihua Liu, Pierre Magal, Ousmane Seydi, Glenn Webb. Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data[J]. Mathematical Biosciences and Engineering, 2020, 17(4): 3040-3051. doi: 10.3934/mbe.2020172

    Related Papers:

    [1] Zi Sang, Zhipeng Qiu, Xiefei Yan, Yun Zou . Assessing the effect of non-pharmaceutical interventions on containing an emerging disease. Mathematical Biosciences and Engineering, 2012, 9(1): 147-164. doi: 10.3934/mbe.2012.9.147
    [2] Qinghua Liu, Siyu Yuan, Xinsheng Wang . A SEIARQ model combine with Logistic to predict COVID-19 within small-world networks. Mathematical Biosciences and Engineering, 2023, 20(2): 4006-4017. doi: 10.3934/mbe.2023187
    [3] Adil Yousif, Awad Ali . The impact of intervention strategies and prevention measurements for controlling COVID-19 outbreak in Saudi Arabia. Mathematical Biosciences and Engineering, 2020, 17(6): 8123-8137. doi: 10.3934/mbe.2020412
    [4] Weike Zhou, Aili Wang, Fan Xia, Yanni Xiao, Sanyi Tang . Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak. Mathematical Biosciences and Engineering, 2020, 17(3): 2693-2707. doi: 10.3934/mbe.2020147
    [5] Hao Wang, Di Zhu, Shiqi Li, Robert A. Cheke, Sanyi Tang, Weike Zhou . Home quarantine or centralized quarantine? A mathematical modelling study on the COVID-19 epidemic in Guangzhou in 2021. Mathematical Biosciences and Engineering, 2022, 19(9): 9060-9078. doi: 10.3934/mbe.2022421
    [6] Yue Deng, Siming Xing, Meixia Zhu, Jinzhi Lei . Impact of insufficient detection in COVID-19 outbreaks. Mathematical Biosciences and Engineering, 2021, 18(6): 9727-9742. doi: 10.3934/mbe.2021476
    [7] Jingjing Tian, Jiabing Wu, Yunting Bao, Xiaoyu Weng, Lei Shi, Binbin Liu, Xinya Yu, Longxing Qi, Zhirong Liu . Modeling analysis of COVID-19 based on morbidity data in Anhui, China. Mathematical Biosciences and Engineering, 2020, 17(4): 2842-2852. doi: 10.3934/mbe.2020158
    [8] Jin Guo, Aili Wang, Weike Zhou, Yinjiao Gong, Stacey R. Smith? . Discrete epidemic modelling of COVID-19 transmission in Shaanxi Province with media reporting and imported cases. Mathematical Biosciences and Engineering, 2022, 19(2): 1388-1410. doi: 10.3934/mbe.2022064
    [9] Liping Wang, Jing Wang, Hongyong Zhao, Yangyang Shi, Kai Wang, Peng Wu, Lei Shi . Modelling and assessing the effects of medical resources on transmission of novel coronavirus (COVID-19) in Wuhan, China. Mathematical Biosciences and Engineering, 2020, 17(4): 2936-2949. doi: 10.3934/mbe.2020165
    [10] Jiangbo Hao, Lirong Huang, Maoxing Liu, Yangjun Ma . Analysis of the COVID-19 model with self-protection and isolation measures affected by the environment. Mathematical Biosciences and Engineering, 2024, 21(4): 4835-4852. doi: 10.3934/mbe.2024213
  • We model the COVID-19 coronavirus epidemic in China. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.



    Many mathematical models of the COVID-19 coronavirus epidemic in China have been developed, and some of these are listed in our references [1,2,3,4,5,6,7,8,9]. We develop here a model describing this epidemic, focused on the effects of the Chinese government imposed public policies designed to contain this epidemic, and the number of reported and unreported cases that have occurred. Our model here is based on our model of this epidemic in [10], which was focused on the early phase of this epidemic (January 20 through January 29) in the city of Wuhan, the epicenter of the early outbreak. During this early phase, the cumulative number of daily reported cases grew exponentially. In [10], we identified a constant transmission rate corresponding to this exponential growth rate of the cumulative reported cases, during this early phase in Wuhan.

    On January 23, 2020, the Chinese government imposed major public restrictions on the population of Wuhan. Soon after, the epidemic in Wuhan passed beyond the early exponential growth phase, to a phase with slowing growth. In this work, we assume that these major government measures caused the transmission rate to change from a constant rate to a time dependent exponentially decreasing rate. We identify this exponentially decreasing transmission rate based on reported case data after January 29. We then extend our model of the epidemic to the central region of China, where most cases occurred. Within just a few days after January 29, our model can be used to project the time-line of the model forward in time, with increasing accuracy, to a final size.

    We consider the following system of ordinary differential equations to describe the propagation of the disease

    {S(t)=τ(t)S(t)[I(t)+U(t)],I(t)=τ(t)S(t)[I(t)+U(t)]νI(t),R(t)=ν1I(t)ηR(t),U(t)=ν2I(t)ηU(t). (2.1)

    The initial conditions of system (2.1) are the following

    S(t0)=S0>0,I(t0)=I0>0,R(t0)=0 and U(t0)=U00. (2.2)

    The onset of the epidemic is t0 in days. The population is compartmentalized at each time tt0 into susceptible S(t), asymptomatic infectious I(t), symptomatic infectious who are unreported U(t), and finally symptomatic infectious individuals reported by the public health service R(t). We assume that reported people will non longer participate into the infections because they are isolated. Therefore only infectious individuals belonging to I(t) or U(t) spread the disease. The average time spent in the asymptomatic infectious class is 1/ν days. We assume that once an individual becomes symptomatic (reported or unreported), he will be infectious during an average period of 1/η days.

    Remark 2.1. The transmission rate of asymptomatic infectious individuals is not known [11]. It has been confirmed that asymptomatic transmission occurs [12]. We assume that the asymptomatic transmission rate is the same as the rate for symptomatic individuals for simplicity. For the model simulations it does not change the outcomes very much, as long as the two rates are not significantly different. In future work we will address this issue.

    The parameters of model (2.1) are listed in Table 1 and Figure 1 is a flow diagram describing the model.

    Table 1.  Parameters of the model.
    Symbol Interpretation Method
    t0 Time at which the epidemic started fitted
    S0 Number of susceptible at time t0 fixed
    I0 Number of asymptomatic infectious at time t0 fitted
    U0 Number of unreported symptomatic infectious at time t0 fitted
    τ(t) Transmission rate at time t fitted
    1/ν Average time during which asymptomatic infectious are asymptomatic fixed
    f Fraction of asymptomatic infectious that become reported symptomatic infectious fixed
    ν1=fν Rate at which asymptomatic infectious become reported symptomatic fitted
    ν2=(1f)ν Rate at which asymptomatic infectious become unreported symptomatic fitted
    1/η Average time symptomatic infectious have symptoms fixed

     | Show Table
    DownLoad: CSV
    Figure 1.  Flow chart of the model.

    We use cumulative reported data from the National Health Commission of the People's Republic of China and the Chinese CDC for mainland China. Before February 11, the data was based on confirmed testing. From February 11 to February 15, the data included cases that were not tested for the virus, but were clinically diagnosed based on medical imaging showing signs of pneumonia. There were 17, 409 such cases from February 10 to February 15. The data from February 10 to February 15 specified both types of reported cases. From February 16, the data did not separate the two types of reporting, but reported the sum of both types. We subtracted 17, 409 cases from the cumulative reported cases after February 15 to obtain the cumulative reported cases based only on confirmed testing after February 15. The data is given in Table 2 with this adjustment.

    Table 2.  Cumulative daily reported case data from January 19, 2020 to March 6, 2020, reported for mainland China by the National Health Commission of the People's Republic of China and the Chinese CDC. The data corresponds to cumulative reported cases confirmed by testing.
    Date (January) 19 20 21 22 23 24 25 26 27 28 29 30 31
    Confirmed cases 198 291 440 571 830 1287 1975 2744 4515 5974 7711 9692 11791
    Date (February) 1 2 3 4 5 6 7 8 9 10 11 12 13
    Confirmed cases 14380 17205 20438 24324 28018 31161 34546 37198 40171 42638 44653 46472 48467
    Date (February) 14 15 16 17 18 19 20 21 22 23 24 25 26
    Confirmed cases 49970 51091 53139 55027 56776 57593 58482 58879 59527 59741 60249 60655 61088
    Date (February) 27 28 29
    Confirmed cases 61415 61842 62415
    Date (March) 1 2 3 4 5 6
    Confirmed cases 62617 62742 62861 63000 63143 63242

     | Show Table
    DownLoad: CSV

    We plot the data for daily reported cases and the cumulative reported cases in Figure 2.

    Figure 2.  Daily reported cases data (left) and cumulative reported cases data (right). The epidemic turning point of the reported case data is approximately February 4, 2020 (day 35, day 1 = January 1, 2020).

    In the following we assume that f=0.8. This means that 80% of symptomatic infectious cases are reported while 20% are unreported and are still involved in the spread of the disease. We assume that the incubation period is an average 7 days that is ν=1/7. We also assume that symptomatic individuals (reported or unreported) will be infectious during an average period of 7 days that is η=1/7. The values of these parameters can be readjusted according to the studies that will be carried out during the pandemic.

    As in our previous work [10], we start from the assumption that the cumulative number of cases has an exponential growth in the early phase of the epidemic and satisfy

    CR(t)=χ1exp(χ2t)χ3,tt0

    with values χ1=0.15, χ2=0.38, χ3=1.0. These values of χ1, χ2, and χ3 are fitted to reported case data from January 19 to January 28. We assumed the initial value S0=11,000,000, the population of the city Wuhan, which was the epicenter of the epidemic outbreak where almost all cases in China occurred in this time period. The other initial conditions are

    I0=χ2χ3f(ν1+ν2)=3.3,U0=((1f)(ν1+ν2)η+χ2)I0=0.18.

    The time-dependent transmission rate τ(t) is supposed to be constant during the exponential growth phase of the cumulative number of reported cases and is given by

    τ0=(χ2+ν1+ν2S0)(η+χ2ν2+η+χ2)=4.51×108.

    The initial time is

    t0=1χ2(log(χ3)log(χ1))=5.

    The value of the basic reproductive number is

    R0=(τ0S0ν1+ν2)(1+ν2η)=4.16.

    These parameter formulas were derived in [10].

    After January 23, strong government measures in all of China, such as isolation, quarantine, and public closings, strongly impacted the transmission of new cases. The actual effects of these measures were complex, and we use an exponential decrease for the transmission rate τ(t) to incorporate these effects after the early exponentially increasing phase. The formula for τ(t) during the exponential decreasing phase was derived by a fitting procedure. The formula for τ(t) is

    {τ(t)=τ0,0tN,τ(t)=τ0exp(μ(tN)),N<t, (4.3)

    The date N and the value of μ are chosen so that the cumulative reported cases in the numerical simulation of the epidemic aligns with the cumulative reported case data during a period of time after January 19. We choose N=25 (January 25) for our simulations. We illustrate τ(t) in Figure 3, with μ=0.16. In this way we are able to project forward the time-path of the epidemic after the government imposed public restrictions, as it unfolds.

    Figure 3.  Graph of τ(t) with N=25 (January 25) and μ=0.16. The transmission rate is effectively 0.0 after day 53 (February 22).

    We assume that exponentially increasing phase of the epidemic (as incorporated in τ0) is intrinsic to the population of any subregion of China, after it is has been established in the epidemic epicenter Wuhan. We also assume that the susceptible population S(t) is not significantly reduced over the course of the epidemic. We set τ0=4.51×108, t0=5.0, I(t0)=3.3, and U(t0)=0.18, as in Section 4. We set S(t0) in (2.2) to 1,400,050,000 (the population of mainland China). We set τ(t) in (2.1) to

    {τ(t)=τ0S0/1,400,050,000,0t25,τ(t)=τ0S0/1,400,050,000exp(μ(t25)),25<t, (5.4)

    where S0=11,000,000 (the population of Wuhan). We thus assume that the government imposed restriction measures became effective in reducing transmission on January 25.

    In Figure 4, we plot the graphs of CR(t), CU(t), R(t), and U(t) from the numerical simulation for simulations based on six time intervals for known values of the cumulative reported case data. For each of these time intervals, a value of μ is chosen so that the simulation for that time interval aligns with the cumulative reported case data in that interval. In this way, we are able to predict the future values of the epidemic from early cumulative reported case data.

    Figure 4.  Graphs of CR(t), CU(t), U(t), R(t). The red dots are the reported case data. The value of μ (indicated in each of the sub-figures) is estimated by fitting the model output for each time interval to the cumulative reported case data for that time interval. The final size of cumulative cases is approximately (A) 49,600 reported, 12,400 unreported; (B) and (C) 62, 700 reported, 15, 700 unreported cases; and (D), (E), (F): 63,500 reported, 15,900 unreported.

    In Figure 5, we plot the graphs of the reported cases R(t), the unreported cases U(t), and the infectious pre-symptomatic cases I(t). The blue dots are obtained from the reported cases data (Table 2) for each day beginning on January 26, by subtracting from each day, the value of the reported cases one week earlier.

    Figure 5.  Graphs of R(t), U(t), I(t). The blue dots are the day by day weekly reported data. The turning point of the asymptomatic infectious cases I(t) is approximately day 35 = February 4. The turning point of the reported cases R(t) and the unreported cases U(t) is approximately day 41 = February 10. The turning point of the day by day weekly reported data is approximately day 41.

    Our model transmission rate τ(t) can be modified to illustrate the effects of an earlier or later implementation of the major public policy interventions that occurred in this epidemic. The implementation one week earlier (25 is replaced by 18 in (4.1)) is graphed in Figure 6A. All other parameters and the initial conditions remain the same. The total reported cases is approximately 4500 and the total unreported cases is approximately 1100. The implementation one week later (25 is replaced by 32 in (4.1)) is graphed in Figure 6B. The total reported cases is approximately 820,000 and the total unreported cases is approximately 200,000. The timing of the institution of major social restrictions is critically important in mitigating the epidemic.

    Figure 6.  Graphs of CR(t), CU(t), U(t), R(t). A: The major public policy interventions were implemented one week earlier (January 18). B: The major public policy interventions were implemented one week later (February 1). The one week earlier turning point day is 33 = February 2. The one week later turning point is day 46 = February 15.

    The number of unreported cases is of major importance in understanding the evolution of an epidemic, and involves great difficulty in their estimation. The data from January 19 to February 15 for reported cases in Table 2, was only for confirmed tested cases. Between February 11 and February 15, additional clinically diagnosed case data, based on medical imaging showing signs of pneumonia, was also reported by the Chinese CDC. Since February 16, only tested case data has been reported by the Chinese CDC, because new NHC guidelines removed the clinically diagnosed category. Thus, after February 15, there is a gap in the reported case data that we used up to February 15. The uncertainty of the number of unreported cases for this epidemic includes this gap, but goes even further to include additional unreported cases.

    We assumed previously that the fraction f of reported cases was f=0.8 and the fraction of unreported cases was 1f=0.2. Our model formulation can be applied with varying values for the fraction f. In Figure 7, we provide illustrations with the fraction f=0.4 (Figure 7A) and f=0.6 (Figure 7B). For f=0.4, the formula for the time dependent transmission rate τ(t) in (4.1) involves new values for τ0=4.08×108 and μ=0.148. The initial conditions I0=6.65 and U0=1.09 also have new values. The other parameters and initial conditions remain the same. For f=0.4, the total reported cases is approximately 63,100 and the total unreported cases is approximately 94,700. For f=0.6, the formula for the time dependent transmission rate τ(t) in (4.1) involves new values for τ0=4.28×108 and μ=0.144. The initial conditions I0=4.43 and U0=0.485 also have new values. The other parameters and initial conditions remain the same. For f=0.6, the total reported cases is approximately 63,300 and the total unreported cases is approximately 42,200. From these simulations, we see that estimation of the number of unreported cases has major importance in understanding the severity of this epidemic.

    Figure 7.  Graphs of CR(t), CU(t), U(t), R(t). The red dots are the cumulative reported case data from Table 2. A: f=0.4. The basic reproductive number is R0=5.03. The final size of the epidemic is approximately 157,800 total cases. The turning point of the epidemic is approximately day 41 = February 10. B: f=0.6, The basic reproductive number is R0=4.62. The final size of the epidemic is approximately 105,500 total cases. The turning point is approximately day 41 = February 10.

    The number of days an asymptomatic infected individual is infectious is uncertain. We simulate in Figure 8 the model with ν=1/3 (asymptomatic infected individuals are infectious on average 3 days before becoming symptomatic), and ν=1/5 (asymptomatic infected individuals are infectious on average 5 days before becoming symptomatic). For ν=1/3, τ0=5.75×108, I0=1.48, U0=0.18, R0=2.78, μ=0.0765, N=24. For ν=1/5, τ0=4.90×108, I0=2.38, U0=0.18, R0=3.45, μ=0.098, N=24. Because the asymptomatic infectious periods are shorter, The date N of the effective reduction of the transmission rate due to restriction measures, is one day earlier.

    Figure 8.  Graphs of CR(t), CU(t), U(t), R(t). The red dots are the cumulative reported case data from Table 2. A: ν=1/3. B: ν=1/5. The turning point is approximately day 40 = February 9 for both cases. The final sizes of CR(t) and CU(t) are approximately the same as for ν=1/7 in both cases.

    In Figure 9, we illustrate the importance of the level of government imposed public restrictions by altering the value of μ in formula (4.1). All other parameters and initial conditions are the same as in Figure 4. In Figure 9A we set μ=0.0, corresponding to no restrictions. The final size of cumulative reported cases after 100 days is approximately 1, 080, 000, 000 cases, approximately 270, 000, 000 unreported cases, and approximately 1, 350, 000, 000 total cases. The turning point is approximately day 65 = March 6. In Figure 9B we set μ=0.17, corresponding to a higher level of restrictions than in Figure 4. The final size of cumulative reported cases after 70 days is approximately 45, 300 cases, approximately 11, 300 unreported cases, and approximately 56, 600 total cases. The turning point is approximately day 38 = February 7. The level and timing of government restrictions on social distancing is very important in controlling the epidemic.

    Figure 9.  Graphs of CR(t), CU(t), U(t), and R(t). case data from Table 2. A: μ=0.0 The orange horizontal line is the population of mainland China. B: μ=0.17. A significant reduction of cases occurs compared to the cumulative reported case data (red dots).

    We have developed a model of the COVID-19 epidemic in China that incorporates key features of this epidemic: (1) the importance of the timing and magnitude of the implementation of major government public restrictions designed to mitigate the severity of the epidemic; (2) the importance of both reported and unreported cases in interpreting the number of reported cases; and (3) the importance of asymptomatic infectious cases in the disease transmission. In our model formulation, we divide infectious individuals into asymptomatic and symptomatic infectious individuals. The symptomatic infectious phase is also divided into reported and unreported cases. Our model formulation is based on our work [10], in which we developed a method to estimate epidemic parameters at an early stage of an epidemic, when the number of cumulative cases grows exponentially. The general method in [10], was applied to the COVID-19 epidemic in Wuhan, China, to identify the constant transmission rate corresponding to the early exponential growth phase.

    In this work, we use the constant transmission rate in the early exponential growth phase of the COVID-19 epidemic identified in [10]. We model the effects of the major government imposed public restrictions in China, beginning on January 23, as a time-dependent exponentially decaying transmission rate after January 24. With this time dependent exponentially decreasing transmission rate, we are able to fit with increasing accuracy, our model simulations to the Chinese CDC reported case data for all of China, forward in time from February 15, 2020.

    Our model demonstrates the effects of implementing major government public policy measures. By varying the date of the implementation of these measures in our model, we show that had implementation occurred one week earlier, then a significant reduction in the total number of cases would have resulted. We show that if these measures had occurred one week later, then a significant increase in the total number of cases would have occurred. We also show that if these measures had been less restrictive on public movement, then a significant increase in the total size of the epidemic would have occurred. It is evident, that control of a COVID-19 epidemic is very dependent on an early implementation and a high level of restrictions on public functions.

    We varied the fraction 1f of unreported cases involved in the transmission dynamics. We showed that if this fraction is higher, then a significant increase in the number of total cases results. If it is lower, then a significant reduction occurs. It is evident, that control of a COVID-19 epidemic is very dependent on identifying and isolating symptomatic unreported infectious cases. We also decreased the parameter ν (the reciprocal of the average period of asymptomatic infectiousness), and showed that the total number of cases in smaller. It is also possible to decrease η (the reciprocal of the average period of unreported symptomatic infectiousness), to obtain a similar result. It is evident that understanding of these periods of infectiousness is important in understanding the total number of epidemic cases.

    Our model was specified to the COVID-19 outbreak in China, but it is applicable to any outbreak location for a COVID-19 epidemic.

    This research was partially supported by NSFC and CNRS (Grant Nos. 11871007 and 11811530272) and the Fundamental Research Funds for the Central Universities. Research was also partially supported by CNRS and National Natural Science Foundation of China (Grant No.11811530272).

    The authors declare there is no conflicts of interest.



    [1] D. S. Hui, E. I. Azhar, T. A. Madani, F. Ntoumi, R. Kock, O. Dar, et al., The continuing 2019-nCoV epidemic threat of novel corona viruses to global health - The latest 2019 novel corona virus outbreak in Wuhan, China, Int. J. Infect. Dis., 91 (2020), 264-266. doi: 10.1016/j.ijid.2020.01.009
    [2] H. Nishiura, N. M. Linton, A. R. Akhmetzhanov, Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China Is consistent with substantial human-to-human transmission, J. Clin. Med., 9 (2020), 488.
    [3] K. Roosa, Y. Lee, R. Luo, A. Kirpich, R. Rothenberg, J. M. Hyman, et al., Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, Infect. Dis. Model., 5 (2020), 256-263.
    [4] Y. Shao, J. Wu, IDM editorial statement on the 2019-nCoV, Infect. Dis. Model., 5 (2020), 233-234.
    [5] B. Tang, N. L. Bragazzi, Q. Li, S. Tang, Y. Xiao, J. Wu, An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov), Infect. Dis. Model., 5 (2020), 248-255.
    [6] B. Tang, X. Wang, Q. Li, N. L. Bragazzi, S. Tang, Y. Xiao, et al., Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions, J. Clin. Med., 9 (2020), 462. doi: 10.3390/jcm9020462
    [7] R. N. Thompson, Novel coronavirus outbreak in Wuhan, China, 2020: Intense surveillance Is vital for preventing sustained transmission in new locations, J. Clin. Med., 9 (2020), 498.
    [8] J. T. Wu, K. Leung, G. M. Leung, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study, The Lancet, 395 (2020), 689-697.
    [9] S. Zhao, S. S. Musa, Q. Lin, J. Ran, G. Yang, W. Wang, et al., Estimating the unreported number of novel Coronavirus (2019-nCoV) cases in China in the first half of January 2020: A data-driven modelling analysis of the early outbreak, J. Clin. Med., 9 (2020), 388. doi: 10.3390/jcm9020388
    [10] Z. Liu, P. Magal, O. Seydi, G. Webb, Understanding unreported cases in the 2019-nCov epidemic outbreak in Wuhan, China, and the importance of major public health interventions, Biology, 9 (2020), 50.
    [11] Centers for Disease control and prevention, Healthcare Professionals: Frequently Asked Questions and Answers, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html.
    [12] ARIA BENDIX, A Person Can Carry And Transmit COVID-19 Without Showing Symptoms, Scientists Confirm, BUSINESS INSIDER, 24 February, 2020. Available from: https://www.sciencealert.com/\researchers-confirmed-patients-can-transmit-the-coronavirus-without\-showing-symptoms.
  • This article has been cited by:

    1. Richard A. J. Post, Marta Regis, Zhuozhao Zhan, Edwin R. van den Heuvel, How did governmental interventions affect the spread of COVID-19 in European countries?, 2021, 21, 1471-2458, 10.1186/s12889-021-10257-2
    2. Quentin Griette, Pierre Magal, Clarifying predictions for COVID-19 from testing data: The example of New York State, 2021, 6, 24680427, 273, 10.1016/j.idm.2020.12.011
    3. Raphaël Forien, Guodong Pang, Étienne Pardoux, Estimating the state of the COVID-19 epidemic in France using a model with memory, 2021, 8, 2054-5703, 10.1098/rsos.202327
    4. W. E. FITZGIBBON, J. J. MORGAN, G. F. WEBB, Y. WU, ANALYSIS OF A REACTION–DIFFUSION EPIDEMIC MODEL WITH ASYMPTOMATIC TRANSMISSION, 2020, 28, 0218-3390, 561, 10.1142/S0218339020500126
    5. Renato M. Cotta, Carolina P. Naveira-Cotta, Pierre Magal, Mathematical Parameters of the COVID-19 Epidemic in Brazil and Evaluation of the Impact of Different Public Health Measures, 2020, 9, 2079-7737, 220, 10.3390/biology9080220
    6. Subhas Khajanchi, Kankan Sarkar, Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India, 2020, 30, 1054-1500, 071101, 10.1063/5.0016240
    7. Jean Dolbeault, Gabriel Turinici, E. Augeraud, M. Banerjee, J.-S. Dhersin, A. d'Onofrio, T. Lipniacki, S. Petrovskii, Chi Tran, A. Veber-Delattre, E. Vergu, V. Volpert, Heterogeneous social interactions and the COVID-19 lockdown outcome in a multi-group SEIR model, 2020, 15, 0973-5348, 36, 10.1051/mmnp/2020025
    8. Lionel Roques, Etienne K Klein, Julien Papaïx, Antoine Sar, Samuel Soubeyrand, Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France, 2020, 9, 2079-7737, 97, 10.3390/biology9050097
    9. J. Demongeot, Q. Griette, P. Magal, SI epidemic model applied to COVID-19 data in mainland China, 2020, 7, 2054-5703, 201878, 10.1098/rsos.201878
    10. Tingzhe Sun, Yan Wang, Modeling COVID-19 epidemic in Heilongjiang province, China, 2020, 138, 09600779, 109949, 10.1016/j.chaos.2020.109949
    11. Tô Tat Dat, Protin Frédéric, Nguyen T. T. Hang, Martel Jules, Nguyen Duc Thang, Charles Piffault, Rodríguez Willy, Figueroa Susely, Hông Vân Lê, Wilderich Tuschmann, Nguyen Tien Zung, Epidemic Dynamics via Wavelet Theory and Machine Learning with Applications to Covid-19, 2020, 9, 2079-7737, 477, 10.3390/biology9120477
    12. Qiwei Li, Tejasv Bedi, Christoph U Lehmann, Guanghua Xiao, Yang Xie, Evaluating short-term forecasting of COVID-19 cases among different epidemiological models under a Bayesian framework, 2021, 10, 2047-217X, 10.1093/gigascience/giab009
    13. Seda İğret Araz, Analysis of a Covid-19 model: Optimal control, stability and simulations, 2021, 60, 11100168, 647, 10.1016/j.aej.2020.09.058
    14. Tingzhe Sun, Dan Weng, Estimating the effects of asymptomatic and imported patients on COVID‐19 epidemic using mathematical modeling, 2020, 92, 0146-6615, 1995, 10.1002/jmv.25939
    15. Quentin Griette, Pierre Magal, Ousmane Seydi, Unreported Cases for Age Dependent COVID-19 Outbreak in Japan, 2020, 9, 2079-7737, 132, 10.3390/biology9060132
    16. Guo-Rong Xing, Ming-Tao Li, Li Li, Gui-Quan Sun, The Impact of Population Migration on the Spread of COVID-19: A Case Study of Guangdong Province and Hunan Province in China, 2020, 8, 2296-424X, 10.3389/fphy.2020.587483
    17. Zhong-Kai Guo, Hong Xiang, Hai-Feng Huo, Analysis of an age-structured tuberculosis model with treatment and relapse, 2021, 82, 0303-6812, 10.1007/s00285-021-01595-1
    18. Haitao Song, Zhongwei Jia, Zhen Jin, Shengqiang Liu, Estimation of COVID-19 outbreak size in Harbin, China, 2021, 0924-090X, 10.1007/s11071-021-06406-2
    19. Christophe Besse, Grégory Faye, Dynamics of epidemic spreading on connected graphs, 2021, 82, 0303-6812, 10.1007/s00285-021-01602-5
    20. Francesca Tang, Yang Feng, Hamza Chiheb, Jianqing Fan, The Interplay of Demographic Variables and Social Distancing Scores in Deep Prediction of U.S. COVID-19 Cases, 2021, 0162-1459, 1, 10.1080/01621459.2021.1901717
    21. Cécile Aubert, Emmanuelle Augeraud-Véron, Maria Vittoria Barbarossa, The relative power of individual distancing efforts and public policies to curb the COVID-19 epidemics, 2021, 16, 1932-6203, e0250764, 10.1371/journal.pone.0250764
    22. Aakansha Gupta, Rahul Katarya, Possibility of the COVID-19 third wave in India: mapping from second wave to third wave, 2023, 97, 0973-1458, 389, 10.1007/s12648-022-02425-w
    23. R. Prem Kumar, Sanjoy Basu, Dipankar Ghosh, Prasun Kumar Santra, G. S. Mahapatra, Dynamical analysis of novel COVID ‐19 epidemic model with non‐monotonic incidence function , 2022, 22, 1472-3891, 10.1002/pa.2754
    24. S.Y. Tchoumi, M.L. Diagne, H. Rwezaura, J.M. Tchuenche, Malaria and COVID-19 co-dynamics: A mathematical model and optimal control, 2021, 99, 0307904X, 294, 10.1016/j.apm.2021.06.016
    25. Victor M. Chan, Esteban A. Hernandez-Vargas, Edgar N. Sanchez, 2021, Neural inverse optimal control applied to design therapeutic options for patients with COVID-19, 978-1-6654-3900-8, 1, 10.1109/IJCNN52387.2021.9534240
    26. K. D. Olumoyin, A. Q. M. Khaliq, K. M. Furati, Data-Driven Deep-Learning Algorithm for Asymptomatic COVID-19 Model with Varying Mitigation Measures and Transmission Rate, 2021, 2, 2673-3986, 471, 10.3390/epidemiologia2040033
    27. Fathalla A. Rihan, K. Udhayakumar, Nicola Sottocornola, M.-Naim Anwar, Abdul Q. M. Khaliq, Stability and Bifurcation Analysis of the Caputo Fractional-Order Asymptomatic COVID-19 Model with Multiple Time-Delays, 2023, 33, 0218-1274, 10.1142/S0218127423500220
    28. Quentin Griette, Jacques Demongeot, Pierre Magal, What Can We Learn from COVID-19  Data by Using Epidemic Models with Unidentified Infectious Cases?, 2021, 1556-5068, 10.2139/ssrn.3868852
    29. Kayode Oshinubi, Firas Ibrahim, Mustapha Rachdi, Jacques Demongeot, Functional data analysis: Application to daily observation of COVID-19 prevalence in France, 2022, 7, 2473-6988, 5347, 10.3934/math.2022298
    30. M. L. Diagne, H. Rwezaura, S. Y. Tchoumi, J. M. Tchuenche, Jan Rychtar, A Mathematical Model of COVID-19 with Vaccination and Treatment, 2021, 2021, 1748-6718, 1, 10.1155/2021/1250129
    31. Pradeep K. Jha, Suvadip Ghorai, Rakhi Jha, Rajul Datt, Gowrishankar Sulapu, Surya Prakash Singh, Forecasting the impact of epidemic outbreaks on the supply chain: modelling asymptomatic cases of the COVID-19 pandemic, 2021, 0020-7543, 1, 10.1080/00207543.2021.1982152
    32. József Z. Farkas, Roxane Chatzopoulos, Assessing the Impact of (Self)-Quarantine through a Basic Model of Infectious Disease Dynamics, 2021, 13, 2036-7449, 978, 10.3390/idr13040090
    33. E. Iván Guerrero-Flores, J. Héctor Morales-Bárcenas, Gabriel Núñez-Antonio, 2022, Chapter 7, 978-3-031-12777-9, 115, 10.1007/978-3-031-12778-6_7
    34. Jayrold P. Arcede, Rachel C. Basañez, Youcef Mammeri, 2022, Chapter 7, 978-981-16-7856-1, 75, 10.1007/978-981-16-7857-8_7
    35. Haitao Song, Fang Liu, Feng Li, Xiaochun Cao, Hao Wang, Zhongwei Jia, Huaiping Zhu, Michael Y. Li, Wei Lin, Hong Yang, Jianghong Hu, Zhen Jin, Modeling the second outbreak of COVID-19 with isolation and contact tracing, 2022, 27, 1531-3492, 5757, 10.3934/dcdsb.2021294
    36. Quentin Griette, Jacques Demongeot, Pierre Magal, What can we learn from COVID-19 data by using epidemic models with unidentified infectious cases?, 2021, 19, 1551-0018, 537, 10.3934/mbe.2022025
    37. Jie Long, A. Q. M. Khaliq, K. M. Furati, Identification and prediction of time-varying parameters of COVID-19 model: a data-driven deep learning approach, 2021, 98, 0020-7160, 1617, 10.1080/00207160.2021.1929942
    38. Omaji Samuel, Akogwu Blessing Omojo, Abdulkarim Musa Onuja, Yunisa Sunday, Prayag Tiwari, Deepak Gupta, Ghulam Hafeez, Adamu Sani Yahaya, Oluwaseun Jumoke Fatoba, Shahab Shamshirband, IoMT: A COVID-19 Healthcare System Driven by Federated Learning and Blockchain, 2023, 27, 2168-2194, 823, 10.1109/JBHI.2022.3143576
    39. Nikolaos Stasinos, Anestis Kousis, Vangelis Sarlis, Aristeidis Mystakidis, Dimitris Rousidis, Paraskevas Koukaras, Ioannis Kotsiopoulos, Christos Tjortjis, A Tri-Model Prediction Approach for COVID-19 ICU Bed Occupancy: A Case Study, 2023, 16, 1999-4893, 140, 10.3390/a16030140
    40. Sanjoy Basu, R. Prem Kumar, P.K. Santra, G.S. Mahapatra, A.A. Elsadany, Preventive control strategy on second wave of Covid-19 pandemic model incorporating lock-down effect, 2022, 61, 11100168, 7265, 10.1016/j.aej.2021.12.066
    41. Yan Wang, Feng Qing, Haozhan Li, Xuteng Wang, Timely and effective media coverage's role in the spread of Corona Virus Disease 2019, 2022, 0170-4214, 10.1002/mma.8732
    42. J. Waku, K. Oshinubi, J. Demongeot, Maximal reproduction number estimation and identification of transmission rate from the first inflection point of new infectious cases waves: COVID-19 outbreak example, 2022, 198, 03784754, 47, 10.1016/j.matcom.2022.02.023
    43. Salihu S. Musa, Isa A. Baba, Abdullahi Yusuf, Tukur A. Sulaiman, Aliyu I. Aliyu, Shi Zhao, Daihai He, Transmission dynamics of SARS-CoV-2: A modeling analysis with high-and-moderate risk populations, 2021, 26, 22113797, 104290, 10.1016/j.rinp.2021.104290
    44. Lan Meng, Wei Zhu, Analysis of SEIR epidemic patch model with nonlinear incidence rate, vaccination and quarantine strategies, 2022, 200, 03784754, 489, 10.1016/j.matcom.2022.04.027
    45. Mostafa Bachar, Mohamed A. Khamsi, Messaoud Bounkhel, A mathematical model for the spread of COVID-19 and control mechanisms in Saudi Arabia, 2021, 2021, 1687-1847, 10.1186/s13662-021-03410-z
    46. Paulo Roberto de Lima Gianfelice, Ricardo Sovek Oyarzabal, Americo Cunha, Jose Mario Vicensi Grzybowski, Fernando da Conceição Batista, Elbert E. N. Macau, The starting dates of COVID-19 multiple waves, 2022, 32, 1054-1500, 031101, 10.1063/5.0079904
    47. Tchavdar T. Marinov, Rossitza S. Marinova, Inverse problem for adaptive SIR model: Application to COVID-19 in Latin America, 2022, 7, 24680427, 134, 10.1016/j.idm.2021.12.001
    48. Mustapha Hankar, Marouane Birjali, Abderrahim Beni-Hssane, 2022, Chapter 59, 978-981-16-3636-3, 845, 10.1007/978-981-16-3637-0_59
    49. Abdon Atangana, Seda İgret Araz, 2022, Chapter 8, 978-981-19-0728-9, 237, 10.1007/978-981-19-0729-6_8
    50. Ousmane Koutou, Abou Bakari Diabaté, Boureima Sangaré, Mathematical analysis of the impact of the media coverage in mitigating the outbreak of COVID-19, 2023, 205, 03784754, 600, 10.1016/j.matcom.2022.10.017
    51. Quentin Griette, Zhihua Liu, Pierre Magal, Robin N. Thompson, 2022, Chapter 8, 978-3-030-85052-4, 173, 10.1007/978-3-030-85053-1_8
    52. Isa A. Baba, Usa W. Humphries, Fathalla A. Rihan, J. E. N. Valdés, Fractional–Order Modeling and Control of COVID-19 with Shedding Effect, 2023, 12, 2075-1680, 321, 10.3390/axioms12040321
    53. Fathalla A. Rihan, Udhayakumar Kandasamy, Hebatallah J. Alsakaji, Nicola Sottocornola, Dynamics of a Fractional-Order Delayed Model of COVID-19 with Vaccination Efficacy, 2023, 11, 2076-393X, 758, 10.3390/vaccines11040758
    54. Zhong-Kai Guo, Hai-Feng Huo, Hong Xiang, TRANSMISSION DYNAMICS AND OPTIMAL CONTROL OF AN AGE-STRUCTURED TUBERCULOSIS MODEL, 2024, 14, 2156-907X, 1434, 10.11948/20230248
    55. Aakansha Gupta, Rahul Katarya, A deep-SIQRV epidemic model for COVID-19 to access the impact of prevention and control measures, 2023, 107, 14769271, 107941, 10.1016/j.compbiolchem.2023.107941
    56. Cécile Aubert, Hai-Anh Dang, Manh-Hung Nguyen, The Unequal Impact of Covid-19: Health, Wealth and Behaviors by Income Groups, 2022, Volume XXXVII, 0769-0479, 43, 10.3917/rfe.222.0043
    57. Hippolyte d’Albis, Emmanuelle Augeraud-Véron, Dramane Coulibaly, Rodolphe Desbordes, Covid-19 and mobility: determinant or consequence?, 2024, 77, 0938-2259, 261, 10.1007/s00199-023-01510-3
    58. Zhong-Kai Guo, Hai-Feng Huo, Hong Xiang, Qiu-Yan Ren, Global dynamics of a tuberculosis model with age-dependent latency and time delays in treatment, 2023, 87, 0303-6812, 10.1007/s00285-023-01999-1
    59. Jacques Demongeot, Pierre Magal, Data-driven mathematical modeling approaches for COVID-19: A survey, 2024, 50, 15710645, 166, 10.1016/j.plrev.2024.08.004
    60. Helio Schechtman, Max O. Souza, 2024, Chapter 60, 978-3-031-49400-0, 580, 10.1007/978-3-031-49401-7_60
    61. Padma Bhushan Borah, Hemanta Kumar Sarmah, 2024, Chapter 41, 978-3-031-52964-1, 517, 10.1007/978-3-031-52965-8_41
    62. Mahnoosh Tajmirriahi, Zahra Amini, Rahele Kafieh, Hossein Rabbani, Ali Mirzazadeh, Shaghayegh Haghjooy Javanmard, Statistical Inference of COVID-19 Outbreak, 2022, 12, 2228-7477, 95, 10.4103/jmss.jmss_134_21
    63. R. Prem Kumar, Sanjoy Basu, P. K. Santra, Abdelalim A. Elsadany, Amr Elsonbaty, G. S. Mahapatra, A. Al-khedhairi, Global stability and sensitivity analysis of parameters of Omicron variant epidemic in diverse susceptible classes incorporating vaccination stages, 2023, 1432-7643, 10.1007/s00500-023-09170-0
    64. Bande Ganesh, V. Ravinder Naik, Banothu Ramji, Veerender Aerranagula, B. Sankara Babu, Sandeep Sharma, S. Swadesh Kumar, Predicting the Spread of the Corona Virus Disease Requires Analyzing Data from Cases across Multiple States in India, 2023, 430, 2267-1242, 01153, 10.1051/e3sconf/202343001153
    65. Raúl Guinovart-Díaz, Wilfredo Morales-Lezca, Isidro Abelló-Ugalde, Julián Bravo-Castillero, Kuppalapalle Vajravelu, David Guinovart, Multipopulation mathematical modeling of vaccination campaign of COVID-19 in Cuba, 2025, 0228-6203, 1, 10.1080/02286203.2025.2457762
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7219) PDF downloads(697) Cited by(65)

Figures and Tables

Figures(9)  /  Tables(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog